Short-Term Use of Upadacitinib in Combination With Biologic Therapy for Inducing Clinical Remission in Patients With Active Inflammatory Bowel Disease
Jianyi Yin, Yassin EL‐Najjar, Noelle Cordova, Mary‐Joe Touma, Noelle Nguyen, Moheb Boktor, Ezra Burstein, David Fudman
Abstract
Lay Summary We report that upadacitinib intended for short-term use in combination with biologic therapy appeared to be effective in inducing steroid-free clinical remission in patients with active inflammatory bowel disease, but a substantial proportion of patients required extended use.
Topics & Concepts
MedicineInflammatory bowel diseaseInternal medicineGastroenterologyTerm (time)Crohn's diseaseDiseaseIntensive care medicineQuantum mechanicsPhysicsInflammatory Bowel DiseaseMicroscopic ColitisEosinophilic Esophagitis